NeuroCuple for pain after cesarean delivery
Official title: Management of Postoperative Pain After Cesarean Delivery Using Non-pharmacological Analgesic Device, NeuroCuple™
Run by Inova Health Care Services · NCT07185425 · Data updated 2026-11-12
This study will test whether the NeuroCuple non-drug wearable device can reduce pain and opioid use in women having cesarean delivery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 180 (estimated) |
| Sponsor | Inova Health Care Services Academic / other |
| Locations | 1 site (Falls Church, Virginia) |
| Status | Recruiting |
| Started | October 13, 2025 |
| Main results expected | September 2027 |
| Study ends | September 2027 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT07185425 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult women (18+) undergoing planned or unplanned non-emergent cesarean delivery with a Pfannenstiel incision who can consent in English or Spanish and have intact skin at the patch site are the intended participants.
✕Probably not a fit
People with active drug abuse, chronic opioid use, severe chronic pain, skin conditions preventing patch use, those requiring extended epidural care or complex additional procedures are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, randomized (1:1:1), sham-controlled trial will enroll 180 women undergoing non-emergent cesarean delivery and randomize them to an active NeuroCuple device, a sham device, or standard postoperative care. Devices are placed in the PACU by trained staff and both patients and clinical teams are blinded to active versus sham assignment. Pain scores will be collected during the hospital stay and daily through postoperative day 4, and total opioid consumption will be measured in morphine milligram equivalents through day 4. The trial compares pain intensity and opioid use between active device, sham, and standard care groups to determine whether the device reduces postoperative pain and medication needs.
Why it matters
Potential benefit: If effective, the device could lower postoperative pain and reduce opioid requirements after cesarean delivery.
How similar studies have gone: Similar non-pharmacologic wearable and neuromodulation approaches have shown mixed results in small trials, and direct evidence for NeuroCuple is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female 18 years or older able to provide informed consent in English or Spanish * Scheduled for a planned or unplanned non-emergent cesarean delivery under neuraxial anesthesia * Intact skin surfaces around the operative skin incision area at the site of patch application * Pfannestiel skin incision Exclusion Criteria: * Active drug abuse * Chronic opioid user * Severe chronic pain * Psoriasis vulgaris or other skin conditions precluding safe device application * Subject is concurrently participating in another research study with an investigational drug or medical device that in the Investigator's opinion could impact subject safety or study results * Subject with reasons to maintain an epidural beyond operative room * Subject with complex surgery or subject who may need more than a cesarean surgery with possible tubal sterilization procedure * Subject is deemed not suitable for the study at the discretion of the principal Investigator
Where it's running
-
Inova Fairfax Medical Campus
Falls Church, Virginia, United States Recruiting
Study contacts
- Principal investigator: Antonio Saad, MD — Inova Health Care Services
- Study coordinator: Antonio Saad, MD
- Email: antonio.saad@inova.org
- Phone: 7037766040
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
Anterior Knee Nerves Block vs Femoral Nerve Block for Knee Arthroscopy
This trial tests whether an anterior nerves of the knee (ANK) block provides similar pain relief to a femoral nerve block after knee arthroscopy in adults, aiming to reduce quadriceps weakness.
-
Compare spinal-epidural versus general anesthesia for babies after cesarean delivery
This trial tests whether the type of anesthesia used for cesarean delivery affects newborn hearing in babies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.